Key Segments:
By Material
-
PTFE
-
Biosynthetic
-
Polyurethane
-
Others
By Configuration
-
Conventional Grafts
-
Early-Cannulation Grafts
-
Covered/Stent Grafts
By End User
-
Hospitals
-
Dialysis Centers
-
Ambulatory Surgical Centers
By Graft Site
-
Upper Arm
-
Forearm
-
Thigh
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market includes W. L. Gore & Associates, Merit Medical Systems, Getinge, Artivion, Humacyte, Xeltis, Becton Dickinson, among others. These companies compete on material durability, cannulation speed and outpatient service support.
The main opportunities lie in reimbursement policy shifts that gradually improve the economics of newer device categories, and in the growing population of site-exhausted patients who need specialized thigh or central-vein-bypass graft configurations.
The key growth factor is the steadily rising number of patients reaching end-stage kidney disease and exhausting fistula options, which sustains graft demand largely independent of short-term healthcare spending cycles.
By material, the PTFE segment dominated the market with approximately 43.60% share in 2025, supported by decades of surgical familiarity and a well-understood complication profile.
North America dominated the market with approximately 36.40% share in 2025, supported by its large dialysis-dependent population and established vascular surgery capacity. Asia Pacific is the fastest-growing region with a projected CAGR of 6.95% from 2026 to 2035.
